BridgeBio Pharma BBIO Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$732.94M-34.9% | -$543.35M+16.8% | -$653.25M-34.8% | -$484.65M+17.4% | ||
| $5.43M-10.6% | $6.08M-6.5% | $6.49M-4.1% | $6.77M+15.9% | ||
| $133.02M+38.9% | $95.8M-11.9% | $108.71M+18.7% | $91.56M-8.0% | ||
| -$445.91M— | —— | -$527.72M-25.8% | -$419.49M+15.8% | ||
| $1.1M+17.6% | $933K-28.6% | $1.31M-72.9% | $4.82M-63.6% | ||
| —— | $64.02M+18.3% | $54.1M-88.1% | $453.15M— | ||
| —— | $0— | $0— | $0-100% | ||
| —— | —— | $0— | $0— | ||
| —— | —— | $0-100% | $20.49M— | ||
| —— | $754.19M— | —— | —— | ||
| -$111.1M— | —— | -$22.15M— | —— | ||
| -$447.01M— | —— | -$529.03M-24.7% | -$424.32M+17.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does BridgeBio Pharma generate?
- BridgeBio Pharma (BBIO) generated -$444.0M in operating cash flow over the trailing twelve months.
- What is BridgeBio Pharma's free cash flow?
- After $1.2M of capital expenditures, BridgeBio Pharma's free cash flow was -$445.1M over the trailing twelve months, up 44.0% year over year.
- Where does BridgeBio Pharma's cash flow data come from?
- Every line is extracted from BridgeBio Pharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
